Junliang Fu

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Venues

Signal transduction and targeted therapy

BMJ open

This page only lists publications with an associated author ORCID identifier.

Publications

Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, Huan-Yue Wen, Peng-Hui Yang, Jin-E Lu, Yan Liu, Xi Chen, Meng-Meng Qu, Yang Zhang, Wei-Guo Hong, Yong-Gang Li, Junliang Fu, Fu-Sheng Wang
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study. Signal transduction and targeted therapy 9 (1) (2024)
Chuan Liu, Liting Zhang, Shuairan Zhang, Xiaoguo Li, Yu Jun Wong, Xuan Liang, Yan Wang, Xiaofeng Wu, Wei Gou, Jiaojian Lv, Shengjuan Hu, Junliang Fu, Ju Huang, Guohong Ge, Mingxing Huang, Fang Wang, Qingge Zhang, Tao Ren, Zhong Ji Meng, Deping Ding, Basang Zhuoga, Cidan Zhuoga, Jian Fan, Dianjie Dang, Liang Miao, Zhaomin Song, Xingguo Xiao, Huili Wu, Kai Jiang, Tianyu Liu, Youfang Gao, Lan Ma, Tao Fang, Yuehua Wang, Qianhua Zhang, Da Zhu, Dong Ji, Zhujun Cao, Qing-Lei Zeng, Jie Li, Ping Chen, Yufang Wei, Zhaowei Tong, Zhongsi Hong, Xiao Liang, Yiling Li, Yuemin Nan, Xiaolong Qi
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China. BMJ open 14 (7) (2024)
Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, Huan-Yue Wen, Peng-Hui Yang, Jin-E Lu, Yan Liu, Xi Chen, Meng-Meng Qu, Yang Zhang, Wei-Guo Hong, Yong-Gang Li, Junliang Fu, Fu-Sheng Wang
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study. Signal transduction and targeted therapy 9 (1) (2024)
Hong-Hong Liu, Yunbo Xie, Bao-Peng Yang, Huan-Yue Wen, Peng-Hui Yang, Jin-E Lu, Yan Liu, Xi Chen, Meng-Meng Qu, Yang Zhang, Wei-Guo Hong, Yong-Gang Li, Junliang Fu, Fu-Sheng Wang
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study. Signal transduction and targeted therapy 9 (1) (2024)
Chuan Liu, Liting Zhang, Shuairan Zhang, Xiaoguo Li, Yu Jun Wong, Xuan Liang, Yan Wang, Xiaofeng Wu, Wei Gou, Jiaojian Lv, Shengjuan Hu, Junliang Fu, Ju Huang, Guohong Ge, Mingxing Huang, Fang Wang, Qingge Zhang, Tao Ren, Zhong Ji Meng, Deping Ding, Basang Zhuoga, Cidan Zhuoga, Jian Fan, Dianjie Dang, Liang Miao, Zhaomin Song, Xingguo Xiao, Huili Wu, Kai Jiang, Tianyu Liu, Youfang Gao, Lan Ma, Tao Fang, Yuehua Wang, Qianhua Zhang, Da Zhu, Dong Ji, Zhujun Cao, Qing-Lei Zeng, Jie Li, Ping Chen, Yufang Wei, Zhaowei Tong, Zhongsi Hong, Xiao Liang, Yiling Li, Yuemin Nan, Xiaolong Qi
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China. BMJ open 14 (7) (2024)

Junliang Fu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Junliang Fu